Regen BioPharma Inc (RGBP)

[Golden Cross]

FORM 8-K - CURRENT REPORT
https://www.otcmarkets.com/filing/html?id=14862473&guid=n9ipUFKzGmX22th

Item 8.01 Other Events.

Regen Biopharma, Inc. (the “Company”) is in the process of preparing financial statements in order that Company may have such statements audited (in the case of Annual Financial Statements) and reviewed (in the case of Quarterly Financial Statements).

Upon completion of the aforementioned audits and reviews and preparation of the required reports, the Company intends file the following delinquent periodic reports with United States Securities and Exchange Commission:

• Form 10-K for the Fiscal Year ended September 30, 2019
• Form 10-Q for the Quarter ended December 31, 2019
• Form 10-Q for the Quarter ended March 31, 2020
• Form 10-Q for the Quarter ended June 30, 2020
• Form 10-K for the Fiscal Year ended September 30, 2020
• Form 10-Q for the Quarter ended December 31, 2020